Director's Dealing • Sep 26, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6527A
CVS Group plc
26 September 2022
26 September 2022
CVS Group plc
("CVS" or the "Company")
PDMR Dealings
CVS, one of the UK's leading providers of integrated veterinary services, announces that it was notified on 23 September 2022 of the following share purchases:
· Ben Jacklin, Chief Operating Officer of the Company and his wife purchased a total of 2,455 ordinary shares of 0.2p each in the Company ("Ordinary Shares"). As a result, Mr Jacklin's total interest in the Company, including his wife's holdings, is now 7,901 Ordinary Shares, representing 0.011 per cent of the total voting rights of the Company.
· David Wilton, Non-Executive Director of the Company purchased 1,000 Ordinary Shares. As a result Mr Wilton's total interest in the Company is now 6,500 Ordinary shares, representing 0.009 per cent of the total voting rights of the Company.
· Richard Fairman's wife purchased a total of 1,205 Ordinary Shares. As a result, Mr Fairman's total interest in the Company, including his wife's holdings, is now 30,667 Ordinary Shares, representing 0.017 per cent of the total voting rights of the Company.
The notifications below, made in accordance with the requirements of UK MAR, provide further detail.
| Contacts: CVS Group plc Jenny Farrer Company Secretary |
via MHP Communications |
| Peel Hunt (Nominated Adviser & Broker) Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose |
+44 (0)20 7418 8900 |
| MHP Communications (Financial PR) Andrew Jaques / Simon Hockridge / Rachel Farrington / Charles Hirst |
+44 (0) 20 3128 8549 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ben Jacklin
2
Reason for the notification
a)
Position/status
PDMR (Chief Operating Officer)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 1,627.01 | 1,228 |
d)
Aggregated information
- Aggregated volume
- Price
N/A - Single Transaction
e)
Date of the transaction
23 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Katherine Jacklin
2
Reason for the notification
a)
Position/status
PCA of a Director (Chief Operating Officer)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 1,628.28 | 1,227 |
d)
Aggregated information
- Aggregated volume
- Price
N/A - Single Transaction
e)
Date of the transaction
23 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
David Wilton
2
Reason for the notification
a)
Position/status
PDMR (Non-Executive Director)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 1,618.53 | 1,000 |
d)
Aggregated information
- Aggregated volume
- Price
N/A - Single Transaction
e)
Date of the transaction
23 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Louise Fairman
2
Reason for the notification
a)
Position/status
PCA of a Director (Chief Executive Officer)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 1,658.54 | 1,205 |
d)
Aggregated information
- Aggregated volume
- Price
N/A - Single Transaction
e)
Date of the transaction
23 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAENKASSAEFA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.